ArticleFrontiers in genetics2026
Risk factors and early warning scoring system for chronic postsurgical pain following video-assisted thoracoscopic surgery in elderly lung cancer patients: a retrospective cohort study.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic postsurgical pain (CPSP) is a clinically significant and frequently underrecognized complication of video-assisted thoracoscopic surgery (VATS) for lung cancer, affecting a substantial proportion of elderly patients and adversely impacting quality of life and long-term recovery. In elderly populations, the risk of CPSP is compounded by age-related physiological vulnerabilities, high comorbidity burden, and psychosocial factors that predispose to central sensitization and pain chronification. Despite growing awareness of CPSP as a distinct clinical entity under the IASP ICD-11 classification, validated risk stratification tools specific to elderly patients undergoing VATS remain lacking. This study aims to identify independent clinical risk factors for CPSP following VATS in elderly lung cancer patients and to develop a practical, evidence-based early warning scoring system to support preoperative risk stratification and targeted preventive interventions. Methods: A retrospective cohort study was conducted on 200 elderly patients (aged ≥65 years) who underwent VATS for lung cancer from 12 November 2023 to 13 August 2025 at a tertiary care center and were categorized into the CPSP group (n = 100) and non-CPSP group (n = 100) based on pain persistence beyond 3 months postoperatively. Comprehensive demographic, clinical, surgical, and perioperative data were collected. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors. A predictive scoring system was developed based on regression coefficients, and its discriminatory performance was assessed using receiver operating characteristic (ROC) curve analysis. Results: The overall incidence of CPSP was 50.0% (100/200) in this elderly cohort. Multivariate logistic regression identified seven independent risk factors: advanced age (≥75 years, OR = 3.24, 95% CI: 1.78-5.89, p < 0.001), female gender (OR = 2.16, 95% CI: 1.24-3.76, p = 0.007), preoperative chronic pain (OR = 4.52, 95% CI: 2.15-9.51, p < 0.001), anxiety/depression (OR = 2.87, 95% CI: 1.52-5.42, p = 0.001), extensive lymph node dissection (OR = 3.08, 95% CI: 1.65-5.75, p < 0.001), intraoperative blood loss >50 mL (OR = 2.45, 95% CI: 1.32-4.54, p = 0.005), and inadequate acute postoperative pain control (OR = 3.76, 95% CI: 1.98-7.14, p < 0.001). A 0-17 point early warning scoring system was established: low risk (0-4 points, CPSP probability 8.3%), moderate risk (5-8 points, 47.7%), and high risk (≥9 points, 84.4%). The scoring system demonstrated good discriminatory performance with AUC of 0.847 (95% CI: 0.794-0.900), sensitivity 82.0%, and specificity 78.0% at the optimal cut-off of 7 points, pending external validation. Conclusion: This study identified seven independent risk factors for CPSP following VATS in elderly lung cancer patients and established a practical early warning scoring system with good predictive performance (AUC = 0.847), enabling preoperative risk stratification and facilitating targeted preventive interventions to improve long-term outcomes. External multicenter validation is warranted before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.